Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.
about
Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat.Further evidence for the association of CYP2D6*4 gene polymorphism with Parkinson's disease: a case control studyAstrocytes and therapeutics for Parkinson's disease.Neurotoxic effects of tetrahydroisoquinolines and underlying mechanismsThe organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine with unexpected mechanism of action: new vistas of therapeutic application.Protection of intracellular dopamine cytotoxicity by dopamine disposition and metabolism factors.Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholamines.Antidepressants, sertraline and paroxetine, increase calcium influx and induce mitochondrial damage-mediated apoptosis of astrocytes.Site of action of suramin and reactive blue 2 in preventing neuronal death induced by dequalinium.4-Organoseleno-Isoquinolines Selectively and Reversibly Inhibit the Cerebral Monoamine Oxidase B Activity.
P2860
Q33671819-58FB4801-0F11-4A2B-A12F-DCD2397D8B5EQ33861662-29AB2E2B-A5EB-4625-8E0A-5B35660488F7Q34168266-11614339-570C-4BFA-A9E5-D33A9AA20082Q35545943-F4A43947-06A2-49C4-85ED-6F216E3DD929Q37194765-78D1A3A5-887A-4FEE-8110-8F10D96D988FQ37886152-70167F65-5A65-421C-98DC-1AE813F26754Q38110453-4D16DBD0-025C-4272-A8AE-AB88B59539C9Q40809060-A1B5EF81-0909-4F0F-AF25-BD0BF49AD00AQ46691063-473C096B-3BBE-4671-8FB2-8AB4B40D8DC3Q47642074-D80FD6FC-5DE4-4955-BF97-78600CC8E9EAQ50507943-E203CB47-794A-4159-9252-60F83072541FQ52141765-2CCB5193-55C2-4957-A068-C1321B6A3B12
P2860
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@ast
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@en
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@nl
type
label
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@ast
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@en
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@nl
altLabel
Isoquinoline derivatives as en ...... tiology of Parkinson’s disease
@en
prefLabel
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@ast
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@en
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@nl
P2093
P1476
Isoquinoline derivatives as en ...... iology of Parkinson's disease.
@en
P2093
Altomare C
Carrupt PA
Cellamare S
McNaught KS
P304
P356
10.1016/S0006-2952(98)00142-7
P407
P577
1998-10-01T00:00:00Z